콘텐츠로 건너뛰기
주식/증권 📈 긍정적

2 Reasons to Avoid BMRN and 1 Stock to Buy Instead

요약

BioMarin Pharmaceutical trades at $59.99 per share and has stayed right on track with the overall market, gaining 6.5% over the last six months. At the same time, the S&P 500 has returned 11.4%.